Storia in 2 fonti

RPG Life Sciences launches Naprosyn ES, a first-in-India Naproxen-Esomeprazole combination

The product targets patients on long-term NSAID therapy who face elevated risk of gastrointestinal complications.

Raccontata da

economictimes.indiatimes.com

thehindubusinessline.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo15 g fa

RPG Life Sciences launches Naprosyn ES, a first-in-India Naproxen-Esomeprazole combination

The product targets patients on long-term NSAID therapy who face elevated risk of gastrointestinal complications.

originale

economictimes.indiatimes.com15 g fa

RPG Life Sciences ties-up with Archerchem Healthcare to launch anti-inflammatory solution in India

RPG Life Sciences and Archerchem Healthcare have partnered to launch a new medication. This combination drug offers anti-inflammatory benefits with gastroprotection for patients. RPG Life Sciences will exclusively…

Leggi questa versione →

Timeline cronologica

lunedì 13 luglio 2026·economictimes.indiatimes.com
RPG Life Sciences ties-up with Archerchem Healthcare to launch anti-inflammatory solution in India
RPG Life Sciences and Archerchem Healthcare have partnered to launch a new medication. This combination drug offers anti-inflammatory benefits with gastroprotection for patients.…
lunedì 13 luglio 2026·thehindubusinessline.com
RPG Life Sciences launches Naprosyn ES, a first-in-India Naproxen-Esomeprazole combination
The product targets patients on long-term NSAID therapy who face elevated risk of gastrointestinal complications.